Doctor of Philosophy, University of Toledo, 2020, Medicinal Chemistry
Alzheimer's disease (AD) is a progressive, neurodegenerative disease resulting in cognitive decline, dementia, and eventually death. This work investigates furoxans (1,2,5 oxadiazole N-oxides) for their utility in the treatment of AD. Furoxans are thiol dependent nitric oxide (NO) mimetics, capable of releasing NO in a cellular environment. This work focuses on attenuated furoxans, designed to release NO in a slow, controlled manner to engage the NO/sGC pathway, resulting in in the phosphorylation of CREB, increasing the production of pro-survival gene products such as BDNF.
IS-1-41 was identified as a hit compound, possessing promising biological activity such as: neuroprotection, procognitive effects, and a long systemic half-life. Efforts to explore attenuated furoxans resulted in a library of more than 60 novel attenuated furoxans. Several novel attenuated furoxans were found to be neuroprotective; however, when incubated with cysteine, none were found to breakdown to release NO despite evidence showing neuroprotection was NO/sGC dependent.
We investigated the bioactivation of attenuated furoxans via selenocysteine and found that, while attenuated furoxans breakdown in the presence of selenocysteine, the resulting breakdown product has not released NO. This supports the hypothesis that attenuated furoxans interact with unknown protein target(s) to release NO, providing the observed neuroprotection, which can be further explored via photolytic target ID studies. After extensive pre-clinical development, four lead candidates, IS-1-41, AH-1-91, AH-2-36, and AH-2-87 were identified and are being investigated for their utility in the treatment of AD.
Tangentially, work was undertaken to establish a platform to accomplish in vivo photoaffinity target ID studies to explore the mechanism of action of β-phenethylamines with a non-biased approach. Casper zebrafish were employed as the in vivo model, as casper zebrafish lack melanin and therefore cannot block t (open full item for complete abstract)
Committee: Isaac Schiefer (Committee Chair); William Messer (Committee Member); Zahoor Shah (Committee Member); Erin Prestwich (Committee Member); Wei Li (Committee Member)
Subjects: Analytical Chemistry; Chemistry; Neurosciences; Pharmaceuticals; Pharmacy Sciences